BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35220330)

  • 1. Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
    Han KA; Lee YH; Son HS; Song KH; Kim SY; Chung CH; Jang HC; Lee KW; Cha BY; Song KH; Ko YK; Lee PB; Kim BJ; Kim S; An T; Kim YC
    Clin J Pain; 2022 Feb; 38(5):343-350. PubMed ID: 35220330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain.
    Kang SM; Hong JH; Ku BJ
    Medicine (Baltimore); 2023 Apr; 102(17):e33701. PubMed ID: 37115054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
    Soin A; Bock G; Giordano A; Patel C; Drachman D
    Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial.
    Huffman CL; Goldenberg JN; Weintraub J; Sanin L; Driscoll J; Yang R; Chew ML; Scavone JM
    Clin J Pain; 2017 Jul; 33(7):569-578. PubMed ID: 27753650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial.
    Lee MK; Jeon Y; Choi SS; Lee PB; Kim YC; Suh JH; Sim SE; Song SO; Ko Y; Yu JM; Min K; Lee JH
    Clin Ther; 2020 Dec; 42(12):2266-2279. PubMed ID: 33272643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for neuropathic pain in adults.
    Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
    Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M
    Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
    Smith T; DiBernardo A; Shi Y; Todd MJ; Brashear HR; Ford LM
    Pain Pract; 2014 Apr; 14(4):332-42. PubMed ID: 23692321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
    Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
    Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of twice-daily tramadol hydrochloride bilayer sustained-release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double-blind, placebo-controlled, treatment-withdrawal study.
    Kawai S; Hasegawa J; Ito H; Fukuuchi Y; Nakano H; Ohtani H; Sasaki K; Adachi T
    Pain Pract; 2023 Mar; 23(3):277-289. PubMed ID: 36478501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U; Griesing T; Emir B; Young JP
    Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for acute and chronic pain in adults.
    Moore RA; Straube S; Wiffen PJ; Derry S; McQuay HJ
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007076. PubMed ID: 19588419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting.
    Athanasakis K; Petrakis I; Karampli E; Vitsou E; Lyras L; Kyriopoulos J
    BMC Neurol; 2013 Jun; 13():56. PubMed ID: 23731598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.